The authors showed that the plasma level of anti-nephrin was high in rFSGS patients before transplantation or during recurrence, whereas the anti-nephrin level in nonrecurrent FSGS patients and genetic FSGS patients was comparable with that of control subjects (68). Here, NPHS1 is linked to focal segmental glomerulosclerosis.